Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

about

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

Item

http://www.wikidata.org/entity/Q52665504

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

@en

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

@nl

type

Item

label

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

@en

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

@nl

prefLabel

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

@en

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung.

@nl

P1476

Immune cell landscape in therapy-naïve squamous cell and adenocarcinomas of the lung

@en

P2093

Arschang Valipour

http://www.w3.org/2001/XMLSchema#string

Dagmar Krenbek

http://www.w3.org/2001/XMLSchema#string

Franz Quehenberger

http://www.w3.org/2001/XMLSchema#string

Gudrun Absenger

http://www.w3.org/2001/XMLSchema#string

Helmut H Popper

http://www.w3.org/2001/XMLSchema#string

Herbert Stoeger

http://www.w3.org/2001/XMLSchema#string

Joerg Lindenmann

http://www.w3.org/2001/XMLSchema#string

Marija Balic

http://www.w3.org/2001/XMLSchema#string

Melanie Fediuk

http://www.w3.org/2001/XMLSchema#string

Mohamed Al Effah

http://www.w3.org/2001/XMLSchema#string

P2860

Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cells

Understanding the function and dysfunction of the immune system in lung cancer: the role of immune checkpoints

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment.

Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer.

Pan-Bcl-2 inhibitor, GX15-070 (obatoclax), decreases human T regulatory lymphocytes while preserving effector T lymphocytes: a rationale for its use in combination immunotherapy

Dopamine D2 receptor agonists inhibit lung cancer progression by reducing angiogenesis and tumor infiltrating myeloid derived suppressor cells.

Human cancer immunotherapy with antibodies to the PD-1 and PD-L1 pathway.

P2888

s00428-018-2326-0

P304

589-598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-018-2326-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

472

http://www.w3.org/2001/XMLSchema#string

P50

Luka Brcic

P577

2018-03-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29520483

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

P932

5924661

http://www.w3.org/2001/XMLSchema#string